Inmunobiología e inmunomodulación parasitaria
INMUNOPAR
Centro de Investigación Biomédica en Red sobre Enfermedades Hepáticas y Digestivas
Madrid, EspañaPublicacions en col·laboració amb investigadors/es de Centro de Investigación Biomédica en Red sobre Enfermedades Hepáticas y Digestivas (7)
2023
2022
-
Lentinula edodes extract increases goblet cell number and Muc2 expression in an intestinal inflammatory model of Trichinella spiralis infection
Biomedicine and Pharmacotherapy, Vol. 150
2020
-
Impact of global PTP1B deficiency on the gut barrier permeability during NASH in mice
Molecular Metabolism, Vol. 35
2019
-
Effectiveness and safety of the switch from remicade® to CT-P13 in patients with inflammatory bowel disease
Journal of Crohn's and Colitis, Vol. 13, Núm. 11, pp. 1380-1386
2015
-
Efficacy and toxicity evaluation of new amphotericin B micelle systems for brain fungal infections
International Journal of Pharmaceutics, Vol. 494, Núm. 1, pp. 17-22
2014
-
Enhanced bioavailability and anthelmintic efficacy of mebendazole in redispersible microparticles with low-substituted hydroxypropylcellulose
Drug Design, Development and Therapy, Vol. 8, pp. 1467-1479
2011
-
Changed crystallinity of mebendazole solid dispersion: Improved anthelmintic activity
International Journal of Pharmaceutics, Vol. 403, Núm. 1-2, pp. 23-28